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Objective
The prevalence of Type 2 Diabetes in the UK during 2013
was 0.6%, equating to 3.2 million people. Forecasts indicate
that three people will be diagnosed every ten minutes by
2025. Ineffective methods or delays in thorough patient
education leaves the patient at risk of developing foot com-
plications among wider issues of morbidity. This research
aimed to test the efficacy of patient education for Type 2
Diabetes by analysing patients’ views following their educa-
tional programme. The project aimed to highlight the value
of such education programmes and to encourage wider
holistic awareness of education in patient management.
Method
With School of Health ethical committee approval, a focus
group was formed using a random sample of seven con-
senting Podiatry patients from a UK School of Podiatry.
All patients had a diagnosis of Type 2 Diabetes and had
attended an educational programme at some point over
the last 12 years. The researcher initiated discussion with
questions to the group and a one hour discussion was
transcribed. This was defined using Nvivo 10 software and
thematic analysis was employed to look at quality, recur-
rent themes and their significance in relation to the exist-
ing evidence base. The primary outcome measure was
comprehension. Positive and negative perceptions were
defined into subthemes to measure specific outcomes.
Outcome
This qualitative research study considered the efficacy of
educational programmes for patients with a diagnosis of
Type 2 Diabetes, using patients’ perceptions. Contexts
around stabilisation of glucose levels, quality of life,
patient adherence and relationships were analysed.
Although diet was quantifiably discussed, reference to
comprehension and consistency of patient education
were defined in order to answer the research question.
Compared to current evidence, measures of group ver-
sus individual education, biomedical outcomes in the
disease process and perceptions via questionnaires, this
study found structure of education programmes to be
the underlying key to successful outcomes.
Discussion
Effectual education is reliant upon collaborative interven-
tions of all Health Care Professionals, so that consistent
information is delivered and patients get the practical skills
required to self-manage their Diabetes. Furthermore,
patients’ knowledge of their condition plays a valuable
adjunct to basic awareness of Diabetic foot disease.
Though there are many programmes available, it is evident
that some patients newly diagnosed and some with long
standing Type 2 Diabetes have limited knowledge of their
condition. They feel anxious and confused, however; the
majority of patients embrace the chance to share their
story and knowledge, feeling empowered upon doing this.
This study has served as a useful pilot study and com-
pared existing literature with the presenting qualitative evi-
dence, however; for future research in this area a wider
study is recommended to further investigate patient trends
in a larger population. Moreover recommended are all
practitioners involved ensure patient education forms part
of a treatment plan and that we ensure, as professionals, we
constantly question our practice. How do we educate best,
and are the messages consistent in our delivery of patient
education?
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